The global Fluorescein Angiography Market size is expected to reach USD 617.4 million by the end of 2027, expanding at a CAGR of 2.7%, according to a new report by Grand View Research, Inc. Increasing prevalence of ophthalmic conditions such as macular degeneration and diabetic retinopathy and rapid technological advancements are some of the high impact-rendering market drivers. However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.
End-users such as hospitals and imaging centers in the country are effectively adopting AI-based fundus cameras for detecting various blindness-causing diseases. For instance, in January 2019, Deqing County hospital in Guangdong Province conducted a free consultation by featuring an AI camera codeveloped by Sun Yat-sen University and Baidu-a multinational technology company in China that offers services, including a search engine platform-to detect ocular fundus diseases. This AI fundus camera is capable of diagnosing glaucoma, diabetic retinopathy, and macular degeneration.
Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions. The technique provides accurate and high quality pictures which help in selecting efficient treatment regimen. In addition, the demand for tradition fluorescein angiography systems is still high in developing countries. This can be attributed to affordability and product availability.
Request a Sample Copy of the Global Fluorescein Angiography Market Research Report @ https://www.grandviewresearch.com/industry-analysis/fluorescein-angiography-market/request/rs1
Fluorescein Angiography Market Report Highlights
- North America accounted for the largest share in 2019 owing to favorable reimbursement policies, high adoption rate of advanced technologies, and increasing prevalence of diabetic retinopathy
- By product, the market is segmented into devices, disposables, and accessories
- The devices segment captured the largest market size in 2019 and is expected to witness a CAGR of 3.0% over the forecast period
- Availability of hybrid devices and technological advancements such as auto-focus and integration with AI are major factors driving the devices segment
- Based on application, the market is segmented into macular edema, macular degeneration, macular pucker, ocular melanoma, diabetic retinopathy, and others
- Macular degeneration and diabetic retinopathy captured the largest market share in 2019
Have Any Query? Ask Our Experts@ https://www.grandviewresearch.com/inquiry/450347/ibb
Fluorescein Angiography Market Segmentation
Grand View Research has segmented the global fluorescein angiography market based on product, technology, application, and region:
Fluorescein Angiography Product Outlook (Revenue, USD Million, 2016 – 2027)
- Device
- Disposables
- Dye
- Film
- Accessories
Fluorescein Angiography Technology Outlook (Revenue, USD Million, 2016 – 2027)
- Digital
- Analog
Fluorescein Angiography Application Outlook (Revenue, USD Million, 2016 – 2027)
- Macular edema
- Macular degeneration
- Macular pucker
- Ocular melanoma
- Diabetic retinopathy
- Others
Fluorescein Angiography Regional Outlook (Revenue, USD Million, 2016 – 2027)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Asia Pacific
- Japan
- China
- India
- Malaysia
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Qatar
List of Key Players of Fluorescein Angiography Market
- Carl Zeiss Meditec, Inc.
- NIDEK Co., Ltd.
- Kowa Company Ltd.
- Topcon Medical Systems, Inc.
- Optomed Oy (Ltd.)
- CenterVue SpA
- Canon, Inc.
Browse Related Reports @
Point Of Care CT Imaging Market: https://www.grandviewresearch.com/industry-analysis/point-of-care-ct-imaging-market
Sleep Apnea Diagnostic Devices Market: https://www.grandviewresearch.com/industry-analysis/sleep-apnea-diagnostic-and-therapeutic-devices-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/fluorescein-angiography-market